EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort

Gary Duclos iD, Mohamed Boucekine, Alexis Tabah, Stéphane Ruckly, Niccolò Buetti, Jean François Timsit, Marc Leone, EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP, OUTCOMEREA Network

PLOS One · 2026

DOI: 10.1371/journal.pone.0356721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Gary Duclos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Unit, Hospital Nord, Assistance Publique Hôpitaux Universitaires de Marseille, Marseille, France. Hauptthemen laut MEDLINE: Hydrocortisone, Sepsis, Cross Infection. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Corticosteroids are suggested for selected patients with septic shock, but their association with outcomes has not been specifically investigated in patients with hospital-acquired bloodstream infections (HA-BSI). We explored the association between hydrocortisone use and day-28 mortality in this population.

Methods

Data from the prospective EUROBACT-2 study were used to assess the association between hydrocortisone use and day-28 mortality in ICU patients with HA-BSI and sepsis. Patients receiving hydrocortisone were compared with patients not receiving hydrocortisone. A 1:1 propensity score matching procedure was performed using nearest-neighbour matching without replacement and a caliper of 0.2 standard deviation of the logit propensity score, followed by multivariable logistic regression with cluster-robust standard errors by matched pair.

Results

Among 2,401 analyzed patients, 608 (25%) received hydrocortisone during the HA-BSI episode. The final propensity score included age, sex, Charlson comorbidity score, ICU admission diagnosis, SOFA score without cardiovascular component, septic shock, country of inclusion, lactate at HA-BSI diagnosis, and ICU-acquired versus non-ICU-acquired HA-BSI. Matching yielded 521 pairs (1,042 patients). In the multivariable model, hydrocortisone use was associated with increased day-28 mortality in the overall matched cohort (OR 1.448; 95% CI 1.096–1.914; p = 0.009). This association was observed in patients with sepsis without shock (OR 1.697; 95% CI 1.051–2.740; p = 0.031) and in the female subgroup (OR 1.718; 95% CI 1.055–2.796; p = 0.030), but not in patients with septic shock or in those receiving norepinephrine-equivalent dose ≥0.25 µg/kg/min.

Conclusion

Hydrocortisone use was not associated with improved day-28 survival in ICU patients with HA-BSI. In the matched analysis, hydrocortisone use was associated with higher day-28 mortality in the overall cohort, whereas no significant association was observed in patients with septic shock or high-dose norepinephrine. These findings are observational and hypothesis-generating and should not be interpreted causally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrocortisoneSepsisCross InfectionHumansFemaleMaleAgedMiddle AgedIntensive Care UnitsPropensity ScoreProspective StudiesTreatment OutcomeShock, SepticHospital MortalityCohort Studies

Substanzen

Hydrocortisone

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care Unit, Hospital Nord, Assistance Publique Hôpitaux Universitaires de Marseille, Marseille, France.
  • Centre d'Etudes et de Recherches sur les services de santé et qualité de vie EA 3279, Aix Marseille Université, Marseille, France.
  • Intensive Care Unit, Redcliffe Hospital, Brisbane, Australia.
  • Queensland University of Technology, Brisbane, Queensland, Australia.
  • Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Université de Paris, INSERM, IAME UMR 1137, Paris, France.

ORCID-Profile: Gary Duclos

Zitieren

APA

Duclos, G., Boucekine, M., Tabah, A., Ruckly, S., Buetti, N., Timsit, J. F., Leone, M., EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP, & OUTCOMEREA Network (2026). Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort. PLOS One. https://doi.org/10.1371/journal.pone.0356721

Vancouver

Duclos G, Boucekine M, Tabah A, Ruckly S, Buetti N, Timsit JF, et al. Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort. PLOS One. 2026. doi:10.1371/journal.pone.0356721

BibTeX
@article{Duclos2026,
  author = {Duclos, Gary and Boucekine, Mohamed and Tabah, Alexis and Ruckly, Stéphane and Buetti, Niccolò and Timsit, Jean François and Leone, Marc and EUROBACT-2 Study Group, EUROBACT-2 Study Group and ESICM, ESICM and ESCMID ESGCIP, ESCMID ESGCIP and OUTCOMEREA Network, OUTCOMEREA Network},
  title = {Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0356721}
}
Kostenlos starten →